SIC
DTIL icon

Salem Investment Counselors’s Precision BioSciences DTIL Stock Holding History

Salem Investment Counselors’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3
Closed -$53 – 1130
2023
Q2 		$53 Hold
3
– – ﹤0.01% 1132
2023
Q1 		$76 Hold
3
– – ﹤0.01% 1097
2022
Q4 		$119 Hold
3
– – ﹤0.01% 1065
2022
Q3 		$0 Hold
3
– – ﹤0.01% 1054
2022
Q2 		$0 Hold
3
– – ﹤0.01% 1084
2022
Q1 		$0 Hold
3
– – ﹤0.01% 1027
2021
Q4 		$1K Hold
3
– – ﹤0.01% 1032
2021
Q3 		$1K Hold
3
– – ﹤0.01% 934
2021
Q2 		$1K Buy
+3
New +$901 ﹤0.01% 859

Other funds holding DTIL

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
OMC
OUP Management Company Bala Cynwyd, Pennsylvania $44.5M AUM 55.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Salem Investment Counselors's DTIL Position: Q3 2023 in Review

Salem Investment Counselors sold out of Precision BioSciences (DTIL) in Q3 2023, closing a stake of 3 shares — an estimated $53 sold.

Salem Investment Counselors first reported a position in DTIL in Q2 2021 and held it in 9 quarters. The position peaked at $1K in Q4 2021. 76 funds tracked by Wall St. Rank hold DTIL as of Q3 2023.

  • Salem Investment Counselors reported no remaining Precision BioSciences position as of Q3 2023 after selling out during the quarter.
  • Salem Investment Counselors sold 3 Precision BioSciences shares in Q3 2023, an estimated $53.
  • Salem Investment Counselors first reported a position in Precision BioSciences in Q2 2021 and held it in 9 quarters.
  • Salem Investment Counselors's Precision BioSciences position peaked at $1K in Q4 2021.
  • 76 funds tracked by Wall St. Rank held Precision BioSciences as of Q3 2023.

Based on Salem Investment Counselors's 13F filing for Q3 2023, filed 4 Oct 2023.